Selenoprotein Genes Exhibit Differential Expression Patterns Between Hepatoma HepG2 and Normal Hepatocytes LO2 Cell Lines

Biological Trace Element Research

Volumn 167, Issue 2, 2015, Pages 236-241

  Zhao, Hua ^a   Tang, Jiayong ^a   Xu, Jingyang ^a   Cao, Lei ^a   Jia, Gang ^a   Long, Dingbiao ^b   Liu, Guangmang ^a   Chen, Xiaoling ^a   Wang, Kangning ^a  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

^b Chongqing Academy of Animal Sciences   (China)

Author keywords

Expression; HepG2 cells; LO2 cells; Selenoprotein

Indexed keywords

CASPASE 3; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 3; MESSENGER RNA; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; SYNAPTOPHYSIN; SELENOPROTEIN; TUMOR PROTEIN;

ARTICLE; BCL2A GENE; BCL2B GENE; CASPASE3 GENE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE; GENE EXPRESSION PROFILING; GPX1 GENE; GPX3 GENE; GPX4 GENE; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL; P38 GENE; REAL TIME POLYMERASE CHAIN REACTION; SELH GENE; SELI GENE; SELO GENE; SELT GENE; SELX GENE; SEPN1 GENE; SEPP GENE; SEPW1 GENE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION; BIOSYNTHESIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; HEPG2 CELL LINE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; SELENOPROTEINS;

EID: 84941177300     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-015-0323-6     Document Type: Article

References (33)

1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S (2012) Cancer treatment and survivorship statistics. CA Cancer J Clin 62:220–241
2. Whanger PD (2004) Selenium and its relationship to cancer: an update dagger. Br J Nutr 91:11–18
3. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG (1996) Effects of seleniumsupplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 276:1957–1963
4. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR, Clark LC (2003) Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91:608–612
5. Irons R, Carlson BA, Hatfield DL, Davis CD (2006) Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J Nutr 136:1311–1317
6. Clark LC, Dalkin B, Krongrad A, Combs GF Jr, Turnbul BW, Slate EH, Witherington R, Herlong JH, Janosko E, Carpenter D (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81:730–734
7. Ip C (1998) Lessons from basic research in selenium and cancer prevention. J Nutr 128:1845–1854
8. Lobanov AV, Hatfield DL, Gladyshev VN (2009) Eukaryotic selenoproteins and selenoproteomes. Biochim Biophys Acta 1790:1424–1428
9. Zhuo P, Diamond AM (2009) Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta 1790:1546–1554
10. Meplan C, Rohrmann S, Steinbrecher A, Schomburg L, Jansen E, Linseisen J, Hesketh J (2012) Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer. PLoS ONE 7(11):e48709
11. Liu J, Hinkhouse MM, Sun W, Weydert CJ, Ritchie JM, Oberley LW, Cullen JJ (2004) Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype. Hum Gene Ther 15:239–250
12. Heirman I, Ginneberge D, Brigelius-Floh´e R, Hendrickx N, Agostinis P, Brouckaert P, Rottiers P, Grooten J (2006) Blocking tumor cell eicosanoid synthesis by GPx 4 impedes tumor growth and malignancy. Free Radic Biol Med 40:285–294
13. Novoselov SV, Calvisi DF, Labunskyy VM, Factor VM, Carlson BA, Fomenko DE, Moustafa ME, Hatfield DL, Gladyshev VN (2005) Selenoprotein deficiency and high levels of selenium compounds can effectively Selenium-biofortified porcine serum on cancer cells inhibit hepatocarcinogenesis in transgenic mice. Oncogene 24:8003–8011
14. Castello G, Scala S, Palmieri G, Curley SA, Izzo F (2010) HCV-Related hepatocellular carcinoma: from chronic inflammation to cancer. Clin Immunol 134:237–250
15. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN (2003) Characterization of mammalian selenoproteomes. Science 300:1439–1443
16. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J lmmunol Methods 65:55–63
17. Liu Y, Zhao H, Zhang QS, Tang JY, Li K, Xia XJ, Wang KN, Li K, Lei XG (2012) Prolonged dietary selenium deficiency or excess does not globally affect selenoprotein gene expression and/or protein production in various tissues of pigs. J Nutr 142(8):1410–1416
18. Zhou JC, Zhao H, Li JG, Xia XJ, Wang KN, ZhangYJ LY, Zhao Y, Lei XG (2009) Selenoprotein gene expression in thyroid and pituitary of young pigs is not affected by dietary selenium deficiency or excess. J Nutr 139:1061–1066
19. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387:296–299
20. Hockenbery D, Nu ez G, Milliman C, Schreiber R, Korsmeyer S (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336
21. Otake Y, Soundararajan S, Sengupta TK, Kio EA, Smith JC, Roman MP (2007) Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl-2 mRNA. Blood 109(7):3069–3075
22. Hwang DY, Cho JS, Oh JH, Shim SB, Jee SW, Lee SH, Seo SJ, Lee SK, Lee SH, Kim YK (2005) Differentially expressed genes in transgenic mice carrying human mutant presenilin-2 (N141I): correlation of selenoprotein M with Alzheimer's disease. Neurochem Res 30(8):1009–1019
23. Rebsch CM, Penna FJ, Copeland PR (2006) Selenoprotein expression is regulated at multiple levels in prostate cells. Cell Res 16(12):940–948
24. Rayman MP (2005) Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64(4):527–542
25. Nasr MA, Fedele MJ, Esser K, Diamond AM (2004) GPx-1 modulates Akt and P70S6K phosphorylation and Gadd45 levels in MCF-7 cells. Free Radic Biol Med 37:187–195
26. Gonzalez-Moreno O, Boque N, Redrado M, Milagro F, Campion J, Endermann T, Takahashi K, Saito Y, Catena R, Schomburg L (2011) Selenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage. Prostate 71:824–834
27. Shibata T, Arisawa T, Tahara T, Ohkubo M, Yoshioka D, Maruyama N, Fujita H, Kamiya Y, Nakamura M, Nagasaka M (2009) SEPS1 gene-105G > A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population. BMC Gastroenterol 9:2
28. Zhuo P, Diamond AM (2009) An analysis of molecular mechanisms by which selenoproteins affect cancer risk and progression. Cancer prevention by selenium. Biochim Biophys Acta 1790:1546–1554
29. Davis CD, Tsuji PA, Milner JA (2012) Selenoproteins and cancer prevention. Annu Rev Nutr 32:73–95
30. Huang C, Ding G, Gu C, Zhou J, Kuang M, Ji Y, He Y, Kondo T, Fan J (2012) Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and down-regulates HIF-1alpha to promote hepatocellular carcinoma invasiveness. Clin Cancer Res 18:3042–3053
31. Guariniello S, Colonna G, Raucci R, Costantini M, Bernardo GD, Bergantino F, Castello G, Costantini S (2014) Structure-function relationship and evolutionary history of the human selenopreotein M (SelM) found over-expressed in hepatocellular carcinoma. Biochim Biophys Acta 1844:447–456
32. Sun LH, Li JG, Zhao H, Shi J, Huang JQ, Wang KN, Xia XJ, Li L, Lei XG (2013) Porcine serum can be biofortified with selenium to inhibit proliferation of three types of human cancer cells. J Nutr 143:1115–1122
33. Valko M, Rhodes CJ, Moncol J, Izakovis M, Mazur M (2007) Free radicals, metals and antioxidant in oxidative stress-induced cancer. Chem Biol Interact 160:1–40